Literature DB >> 15145766

Caffeinol confers cortical but not subcortical neuroprotection after transient focal cerebral ischemia in rats.

Ludmila Belayev1, Larissa Khoutorova, Yongbo Zhang, Andrey Belayev, Weizhao Zhao, Raul Busto, Myron D Ginsberg.   

Abstract

The combination of low-dose ethanol and caffeine (caffeinol) protects cortical areas of the brain from damage produced by distal focal ischemia in rats. There are no data, however, as to whether caffeinol influences injury in subcortical brain regions. Rats were anesthetized with halothane and subjected to 2 h of MCAo by poly-l-lysine-coated intraluminal suture. Caffeinol [a combination of ethanol, 0.33 g/kg, and caffeine, 10 mg/kg (n=5)] or vehicle (0.9% NaCl; n=7) was administered by i.v. infusion over a 2.5-h period beginning 15 min after reperfusion. Neurological status was evaluated daily, and histopathology was quantified at 3 days. Caffeinol therapy significantly improved the neurological score, reduced the total infarct volume (by 52%) and cortical infarct areas at multiple coronal levels, but subcortical infarction and brain swelling were not affected. Copyright 2004 Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15145766     DOI: 10.1016/j.brainres.2004.02.039

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  8 in total

Review 1.  Neuroprotection in cerebral ischemia: emphasis on the SAINT trial.

Authors:  Marcus R Chacon; Matt B Jensen; Justin A Sattin; Justin A Zivin
Journal:  Curr Cardiol Rep       Date:  2008-02       Impact factor: 2.931

Review 2.  Rodent models of focal stroke: size, mechanism, and purpose.

Authors:  S Thomas Carmichael
Journal:  NeuroRx       Date:  2005-07

3.  Neuroprotection by neuregulin-1 in a rat model of permanent focal cerebral ischemia.

Authors:  Yonggang Li; Zhenfeng Xu; Gregory D Ford; Dajoie R Croslan; Tariq Cairobe; Zhenzhong Li; Byron D Ford
Journal:  Brain Res       Date:  2007-09-22       Impact factor: 3.252

4.  The effects of caffeine on L-arginine metabolism in the brain of rats.

Authors:  Ebru Ofluoglu; Hatice Pasaoglu; Aydin Pasaoglu
Journal:  Neurochem Res       Date:  2008-07-10       Impact factor: 3.996

5.  Caffeinol at the receptor level: anti-ischemic effect of N-methyl-D-aspartate receptor blockade is potentiated by caffeine.

Authors:  Xiurong Zhao; Roger Strong; Paisith Piriyawat; Robert Palusinski; James C Grotta; Jaroslaw Aronowski
Journal:  Stroke       Date:  2009-12-31       Impact factor: 7.914

6.  Combined neuroprotective modalities coupled with thrombolysis in acute ischemic stroke: a pilot study of caffeinol and mild hypothermia.

Authors:  Sheryl Martin-Schild; Hen Hallevi; Hashem Shaltoni; Andrew D Barreto; Nicole R Gonzales; Jarek Aronowski; Sean I Savitz; James C Grotta
Journal:  J Stroke Cerebrovasc Dis       Date:  2009 Mar-Apr       Impact factor: 2.136

7.  An extended window of opportunity for G-CSF treatment in cerebral ischemia.

Authors:  Armin Schneider; Rainer Wysocki; Claudia Pitzer; Carola Krüger; Rico Laage; Stefan Schwab; Alfred Bach; Wolf-Rüdiger Schäbitz
Journal:  BMC Biol       Date:  2006-10-18       Impact factor: 7.431

Review 8.  Phase I and Phase II Therapies for Acute Ischemic Stroke: An Update on Currently Studied Drugs in Clinical Research.

Authors:  Cesar Reis; Onat Akyol; Wing Mann Ho; Camila Araujo; Lei Huang; Richard Applegate; John H Zhang
Journal:  Biomed Res Int       Date:  2017-02-14       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.